Rate My Professor Sangarran Ramachandram

Dinesh Sangarran Ramachandram is a Lecturer at the School of Pharmacy, Monash University Malaysia, within the Jeffrey Cheah School of Medicine and Health Sciences. He obtained a BPharm in Pharmacy from SRM Institute of Science and Technology and an MSc in Pharmacy from Universiti Sains Malaysia, and is pursuing a Doctorate by Research from Monash University Malaysia. His career encompasses roles as a Clinical Pharmacist, Quality Assurance and Regulatory Affairs Executive, and engagements with the Malaysian Qualifications Agency and Ministry of Higher Education. He coordinates the Professional Practice IV unit (PHR2012), embedding Evidence-Based Medicine in the curriculum, and teaches clinical pharmacy units such as Comprehensive Care: Respiratory and Gastrointestinal (PHR2041), focusing on acute and comprehensive patient care.

Ramachandram's research specializations include Clinical Pharmacy, Pharmacy Practice, Digital Health, Evidence-Based Medicine, Medication Management, Dementia, Substance Use, Integrative Medicine, Public Health, and Pharmacy Education, aligning with UN Sustainable Development Goals like Good Health and Well-being, Quality Education, Industry Innovation and Infrastructure, Reduced Inequalities, and Partnerships for the Goals. He has produced over 50 publications in peer-reviewed journals, with key contributions such as 'Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study' (2020, The Yale Journal of Biology and Medicine), 'Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia' (2019, Journal of Ethnopharmacology), 'The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials' (2022, Journal of Infection and Chemotherapy), 'The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials' (2022, Immunity, Inflammation and Disease), 'Virtual reality (VR) and augmented reality (AR) in pharmacy education: perspectives among pharmacists in the workforce (a qualitative study)' (2025), and 'Comparative efficacy of liberal and restrictive blood transfusion strategies in anemic patients with acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials' (2025). His accolades include the Merdeka Award Grant for International Attachment (2025), Alzheimer’s Disease International Travel Bursary Award (2024), EduTECH Asia Awards Finalist for Outstanding Industrial Collaboration (2025), DOCQUITY External Funding (2024), and International Medical University Research Grant (2023). He contributes as Executive Committee member of the Alzheimer’s Disease Foundation Malaysia, Internal Auditor for the Association of Integrative Medicine Malaysia, and Network Member of the South East Asia Dementia Research Network, organizing workshops on pharmacy automation and dementia care.